Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-01

Clinical Trial Update: A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects [Phase 4]

View source ↗

Summary

A Phase 4 pilot study evaluating the combination of Kaletra (lopinavir/ritonavir) and Intelence (etravirine) tablets in HIV-naive subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intelence (Etravirine)
  • Kaletra (lopinavir)

Snippet

Sponsor: Therapeutic Concepts | Conditions: HIV Infections | Phase 4 | Status: COMPLETED